News — Foundation Fighting Blindness

Displaying 11–20 of 504

Feb 4, 2025

Foundation Fighting Blindness Hosting Webinar for Eye Care Professionals: Gene Therapies for Inherited Retinal Diseases: The Nuts and Bolts, Challenges, and Opportunities

The free, online event at 7 p.m. ET on March 13, 2025, will feature presentations from Christine Kay, MD, Vitreoretinal Associates in Gainesville, Florida, and Thomas Mendel, MD, PhD, Ohio State University Wexner Medical Center.

Foundation News
Jan 10, 2025

Leber Congenital Amaurosis Research Advances

Recent developments in research on Leber congenital amaurosis

Research News
Jan 10, 2025

Age-Related Macular Degeneration Research Advances

Recent developments in research on age-related macular degeneration.

Research News
Jan 10, 2025

Retinitis Pigmentosa Research Advances

Recent developments in research on retinitis pigmentosa.

Research News
Jan 10, 2025

Stargardt Disease Research Advances

Recent developments in research on Stargardt disease

Research News
Jan 10, 2025

Usher Syndrome Research Advances

Recent developments in research on Usher Syndrome.

Research News
Jan 10, 2025

Atsena to Launch Part B of Phase 1/2 Clinical Trial for XLRS Gene Therapy

The Foundation is a founding investor in Atsena.

Research News
Dec 20, 2024

ViGeneron Receives FDA Authorization to Launch Clinical Trial for mRNA Trans-splicing Gene Therapy for Stargardt Disease

The company is also planning to conduct the clinical trial at sites in the EU.

Research News
Dec 16, 2024

SpliceBio Receives FDA Clearance to Launch Clinical Trial for Stargardt Disease Protein Splicing Therapy

The company has also launched a natural history study of patients to inform the planned clinical trial.

Research News
Dec 13, 2024

Sepul Bio Launches Phase 2b Clinical Trial for USH2A RNA Therapy

Known as ultevursen, the USH2A RNA therapy was licensed from ProQR.

Research News